| Fetal marrow suppression after maternal chemotherapy for leukaemia. | |
| | |
MedLine Citation:
|
PMID: 7529655 Owner: NLM Status: MEDLINE |
Abstract/OtherAbstract:
|
A preterm baby, whose mother received chemotherapy for acute leukaemia during pregnancy, required intensive care because of profound anaemia and neutropenia. Haemopoietic progenitor cell studies showed fetal marrow suppression. Those caring for such mothers and babies should know the possible serious effects chemotherapy for malignancies can have on a developing fetus. Long term follow up of the baby is imperative. |
| | |
Authors:
|
N A Murray; D Acolet; M Deane; J Price; I A Roberts |
Related Documents
:
|
3214385 - Acute fatty liver of pregnancy: clinical features and diagnosis. 21845205 - Mechanisms in the adaptation of maternal β-cells during pregnancy. 20571995 - acute intracranial haemorrhage during delivery--a case report 19198975 - A rare pathological trinity: an appendiceal ectopic pregnancy, acute appendicitis and a... 11157835 - Fertility-sparing surgery, with subsequent pregnancy, in persistent gestational trophob... 12499035 - Emergency contraception: knowledge and use among danish women requesting termination of... |
Publication Detail:
|
Type: Case Reports; Journal Article |
Journal Detail:
|
Title: Archives of disease in childhood. Fetal and neonatal edition Volume: 71 ISSN: 1359-2998 ISO Abbreviation: Arch. Dis. Child. Fetal Neonatal Ed. Publication Date: 1994 Nov |
Date Detail:
|
Created Date: 1995-02-16 Completed Date: 1995-02-16 Revised Date: 2009-11-18 |
Medline Journal Info:
|
Nlm Unique ID: 9501297 Medline TA: Arch Dis Child Fetal Neonatal Ed Country: ENGLAND |
Other Details:
|
Languages: eng Pagination: F209-10 Citation Subset: AIM; IM |
Affiliation:
|
Department of Haematology, Royal Postgraduate Medical School, Hammersmith Hospital, London. |
Export Citation:
|
APA/MLA Format Download EndNote Download BibTex |
| MeSH Terms | |
Descriptor/Qualifier:
|
Acute Disease Adult Anemia / chemically induced*, therapy Antineoplastic Combined Chemotherapy Protocols / adverse effects* Erythropoietin / therapeutic use Etoposide / adverse effects Female Granulocyte Colony-Stimulating Factor / therapeutic use Humans Infant, Newborn Infant, Premature, Diseases / chemically induced*, therapy Leukemia, Myeloid / drug therapy* Neutropenia / chemically induced*, therapy Pregnancy Pregnancy Complications, Neoplastic / drug therapy* Prenatal Exposure Delayed Effects* |
| Chemical | |
Reg. No./Substance:
|
11096-26-7/Erythropoietin; 143011-72-7/Granulocyte Colony-Stimulating Factor; 33419-42-0/Etoposide |
| Comments/Corrections | |
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine
Previous Document: Effect of substance P and protein kinase inhibitors on beta-amyloid peptide-induced proliferation of...
Next Document: Histomorphometric study of mast cells in normal bone, osteoporosis and mastocytosis using a new stai...